{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:46:12Z","timestamp":1771667172224,"version":"3.50.1"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001946","name":"American Skin Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Vogt-Koyanagi-Harada syndrome (VKH) and vitiligo are autoimmune diseases that target melanocytes. VKH affects several organs such as the skin, hair follicle, eyes, ears, and meninges, whereas vitiligo is often limited to the skin and mucosa. Many studies have identified immune genes, pathways and cells that drive the pathogeneses of VKH and vitiligo, including interleukins, chemokines, cytotoxic T-cells, and other leukocytes. Here, we present case studies of 2 canines with VKH and 1 with vitiligo, which occurred spontaneously in client-owned companion dogs. We performed comparative transcriptomics and immunohistochemistry studies on lesional skin biopsies from these cases in order to determine if the immunopathogenesis of autoimmune responses against melanocytes are conserved. In dogs, we found enrichment of T cell gene signatures, with upregulation of IFNG, TNF, PRF1, IL15, CTSW, CXCL10, and CCL5 in both VKH and vitiligo in dogs compared to healthy controls. Similar findings were reported in humans, suggesting that these genes play a role in the pathogenesis of spontaneous VKH and vitiligo. T cell-associated genes, including FOXP3 and TBX21, were enriched, while IGFBP5, FOXO1, and PECAM1 were decreased compared to healthy controls. Further, we identified TGFB3, SFRP2, and CXCL7 as additional potential drivers of autoimmune pigmentary disorders. Future studies exploring the immunopathogenesis of spontaneous autoimmunity will expand our understanding of these disorders, and will be useful in developing targeted therapies, repurposing drugs for veterinary and human medicine, and predicting disease prognosis and treatment response.<\/jats:p>","DOI":"10.3389\/fimmu.2020.590558","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T20:01:27Z","timestamp":1610308887000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada\/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Ista A.","family":"Egbeto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colton J.","family":"Garelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesar","family":"Piedra-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil B.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement N.","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian M.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S94866","article-title":"Vogt-Koyanagi-Harada syndrome - current perspectives","volume":"10","author":"Baltmr","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1547","article-title":"Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"47","author":"Sugita","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B6","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1984.tb00673.x","article-title":"Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harada disease that recognize human melanoma cells","volume":"28","author":"Maezawa","year":"1984","journal-title":"Microbiol Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7323","article-title":"Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease","volume":"165","author":"Yamaki","year":"2000","journal-title":"J Immunol"},{"key":"B9","unstructured":"Identification of Dog VKH Disease and Experimental Model of VKH in Dog\n            HayakawaK\n            YamakiK\n            TakiyamaN\n            KotaniT\n            ItohN\n          2002"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_787_19","article-title":"Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals","volume":"9","author":"Patil","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.78.3.223","article-title":"HLA-DRB1 typing of Vogt-Koyanagi-Harada\u2019s disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410","volume":"78","author":"Shindo","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12348-014-0020-1","article-title":"Influence of molecular genetics in Vogt-Koyanagi-Harada disease","volume":"4","author":"Ng","year":"2014","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"B14","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12517","article-title":"Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-\u03b1) in vitiligo-New insight into pathogenesis of disease","volume":"18","author":"Sushama","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15016","article-title":"The role of interleukins in vitiligo: a systematic review","volume":"32","author":"Gomes","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in Vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Indian J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jdermsci.2018.12.005","article-title":"Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1\/17 cells","volume":"93","author":"Zhang","year":"2019","journal-title":"J Dermatol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"eaam7710","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12917-019-2003-9","article-title":"Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review","volume":"15","author":"Tham","year":"2019","journal-title":"BMC Vet Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00601","article-title":"IGFBP-5 Promotes Fibrosis via Increasing Its Own Expression and That of Other Pro-fibrotic Mediators","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s1534-5807(02)00401-x","article-title":"The forkhead transcription factor Foxo1 regulates adipocyte differentiation","volume":"4","author":"Nakae","year":"2003","journal-title":"Dev Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B26","article-title":"Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease","volume":"42","author":"Gocho","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164206","article-title":"Batf3 Deficiency Reveals a Critical Role for CD8\u03b1+ Dendritic Cells in Cytotoxic T Cell Immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.463","article-title":"A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12864-017-3510-3","article-title":"Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets","volume":"18","author":"Dey-Rao","year":"2017","journal-title":"BMC Genomics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.377","article-title":"IFN-\u03b3, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens","volume":"132","author":"Shi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.09.016","article-title":"Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease","volume":"137","author":"Richmond","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14416","article-title":"Increased expression of CXCR 3 and its ligands in patients with vitiligo and CXCL 10 as a potential clinical marker for vitiligo","volume":"174","author":"Wang","year":"2016","journal-title":"Br J Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2016-0228","article-title":"Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo","volume":"95","author":"Karam","year":"2017","journal-title":"Biochem Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.10.048","article-title":"CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14004","article-title":"Role of chemokines and the corresponding receptors in vitiligo: A pilot study","volume":"45","author":"Yang","year":"2018","journal-title":"J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ni.2744","article-title":"The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin","volume":"14","author":"Mackay","year":"2013","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of interleukin-17 in the pathogenesis of vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","article-title":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","volume":"424","author":"Tembhre","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12355","article-title":"Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development","volume":"28","author":"Zhou","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.22.4.312.5510","article-title":"Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada\u2019s disease","volume":"22","author":"Imai","year":"2001","journal-title":"Curr Eye Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1274960","article-title":"The Association of Chemokine Gene Polymorphisms with VKH and Behcet\u2019s Disease in a Chinese Han Population","volume":"2017","author":"Huang","year":"2017","journal-title":"BioMed Res Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-9863","article-title":"Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease","volume":"53","author":"Wang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23225","article-title":"Differential CXC and CX3C Chemokine Expression Profiles in Aqueous Humor of Patients With Specific Endogenous Uveitic Entities","volume":"59","author":"El-Asrar","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.635398","article-title":"Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behcet\u2019s disease in the Chinese Han population","volume":"37","author":"Chen","year":"2012","journal-title":"Curr Eye Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2010.02401.x","article-title":"IL-10 and TGF-\u03b2 Immunoregulatory Cytokines rather than Natural Regulatory T Cells are Associated with the Resolution Phase of Vogt-Koyanagi-Harada (VKH) Syndrome","volume":"72","author":"Commodaro","year":"2010","journal-title":"Scand J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4114","article-title":"Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.015","article-title":"Transcription Factor Foxo1 Represses T-bet-Mediated Effector Functions and Promotes Memory CD8+ T Cell Differentiation","volume":"36","author":"Rao","year":"2012","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.003","article-title":"An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance","volume":"30","author":"Ouyang","year":"2009","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nature11581","article-title":"Novel Foxo1-dependent transcriptional programs control T reg cell function","volume":"491","author":"Ouyang","year":"2012","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/pcmr.12168","article-title":"Wnt inhibitory factor (WIF)-1 promotes melanogenesis in normal human melanocytes","volume":"27","author":"Park","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0646-4","article-title":"Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis","volume":"297","author":"Kang","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4129","article-title":"Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) and immunoregulation: enhancement of regulatory T cells through PPAR\u03b3-dependent and-independent mechanisms","volume":"178","author":"Wohlfert","year":"2007","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105619200","article-title":"Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor \u03b3 activated by macrophage-derived 12\/15-lipoxygenase ligands","volume":"277","author":"Yang","year":"2002","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002533","article-title":"FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms","volume":"8","author":"Sullivan","year":"2012","journal-title":"PloS Pathog"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2013.11.055","article-title":"The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients","volume":"536","author":"Ozel Turkcu","year":"2014","journal-title":"Gene"},{"key":"B63","unstructured":"Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients\n            GiriPS\n            DwivediM\n            LaddhaNC\n            BegumR\n            BhartiAH\n          10.1111\/pcmr.12862Pigment Cell Melanoma Res332020"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.074062","article-title":"Upregulation of T-bet expression in peripheral blood mononuclear cells during Vogt-Koyanagi-Harada disease","volume":"89","author":"Li","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"B65","article-title":"Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients","volume":"12","author":"Horie","year":"2006","journal-title":"Mol Vis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13961","article-title":"Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo","volume":"44","author":"Liang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e48448","DOI":"10.7554\/eLife.48448","article-title":"Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis","volume":"8","author":"Walsh","year":"2019","journal-title":"Elife"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2017.1402303","article-title":"Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo","volume":"51","author":"Mitra","year":"2017","journal-title":"Free Radic Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2017.71114","article-title":"Neutrophil to lymphocyte ratio in patients with vitiligo","volume":"34","author":"Solak","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1463-5224.2005.04059.x","article-title":"An immunohistochemical study of uveodermatologic syndrome in two Japanese Akita dogs","volume":"8","author":"Carter","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J Exp Med"},{"key":"B77","first-page":"10","article-title":"Using the Student\u2019s t-test with extremely small sample sizes","volume":"18","author":"De Winter","year":"2013","journal-title":"Pract Assess Res Eval"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.09.073","article-title":"Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)","volume":"74","author":"Harris","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.049","article-title":"Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib","volume":"76","author":"Rothstein","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/jvp.12101","article-title":"Oclacitinib (APOQUEL\u00ae) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy","volume":"37","author":"Gonzales","year":"2014","journal-title":"J Vet Pharmacol Ther"},{"key":"B83","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/vde.12047","article-title":"Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis","volume":"24","author":"Cosgrove","year":"2013","journal-title":"Vet Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/vde.12186","article-title":"A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs","volume":"26","author":"Little","year":"2015","journal-title":"Vet Dermatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/vde.12088","article-title":"A blinded, randomized, placebo-controlled trial of the efficacy and safety of the J anus kinase inhibitor oclacitinib (A poquel\u00ae) in client-owned dogs with atopic dermatitis","volume":"24","author":"Cosgrove","year":"2013","journal-title":"Vet Dermatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/vde.12422","article-title":"Skin depigmentation associated with toceranib phosphate in a dog","volume":"28","author":"Cavalcanti","year":"2017","journal-title":"Vet Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0766","article-title":"Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma","volume":"10","author":"Peterson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of Tumor Infiltrating Leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.590558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T20:01:36Z","timestamp":1610308896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.590558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2020.590558"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.590558","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"article-number":"590558"}}